{"id":129220,"date":"2026-07-14T15:50:11","date_gmt":"2026-07-14T15:50:11","guid":{"rendered":"https:\/\/www.europesays.com\/canada\/129220\/"},"modified":"2026-07-14T15:50:11","modified_gmt":"2026-07-14T15:50:11","slug":"dexcom-g7-15-day-cgm-receives-health-canada-approval","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/canada\/129220\/","title":{"rendered":"Dexcom G7 15 Day CGM Receives Health Canada Approval"},"content":{"rendered":"<p><a href=\"https:\/\/www.mpo-mag.com\/top-company-profile\/dexcom\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Dexcom<\/a> revealed that its G7 15 Day continuous glucose monitoring system (CGM) earned Health Canada authorization for adults living with diabetes.<\/p>\n<p>According to the company, the G7 15 Day CGM is the longest-lasting and most accurate CGM system currently authorized by Health Canada. The CGM generates real-time glucose readings for a reportedly industry-leading 15.5 days.<\/p>\n<p>The complex, challenging diabetes condition <a href=\"https:\/\/www.diabetes.ca\/advocacy-policies\/advocacy-reports\/national-and-provincial-backgrounders\/diabetes-in-canada\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">impacts<\/a> over four million Canadians. It necessitates constant management of glucose levels and decision-making in order to manage safely.<\/p>\n<p>\u201cSmall improvements can make a meaningful difference for people living with diabetes,\u201d <a href=\"https:\/\/www.businesswire.com\/news\/home\/20260713940133\/en\/Dexcom-G7-15-Day-Receives-Health-Canada-Authorization-Extending-Wear-and-Continuity-for-Canadian-Adults-Living-with-Diabetes?feedref=JjAwJuNHiystnCoBq_hl-ZuHAZxVRaQvQ0qaekuSK9f3_P53wLuJwyFVA4-mOrLx7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCN1Simk7pbS0xXPOT069Puw%3D%3D\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">said<\/a> Andr\u00e9 C\u00f4t\u00e9, VP and GM of Dexcom Canada. \u201cDexcom G7 15 Day reflects our ongoing commitment to simpler, more seamless diabetes management.\u201d<\/p>\n<p>The system is not yet available for purchase despite its approval by Health Canada.<\/p>\n<p>\u201cOur focus is on ensuring that when the product becomes available, Canadians living with diabetes and their healthcare providers have the support, education, and experience they need from day one,\u201d C\u00f4t\u00e9 went on. \u201cWe look forward to sharing more details as we move closer to availability.\u201d<\/p>\n<p>The G7 15 Day CGM received U.S. Food and Drug Administration (FDA) clearance for adults <a href=\"https:\/\/www.mpo-mag.com\/breaking-news\/fda-oks-dexcom-g7-15-day-continuous-glucose-monitor\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">in April 2025.<\/a> It launched in the U.S. on <a href=\"https:\/\/www.mpo-mag.com\/breaking-news\/dexcom-to-release-g7-15-day-cgm-next-month\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">December 1.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Dexcom revealed that its G7 15 Day continuous glucose monitoring system (CGM) earned Health Canada authorization for adults&hellip;\n","protected":false},"author":2,"featured_media":129221,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[17,42895,42893,42823,12119,42968,1855],"class_list":["post-129220","post","type-post","status-publish","format-standard","has-post-thumbnail","category-canada","tag-canada","tag-cgm","tag-continuous-glucose-monitor","tag-dexcom","tag-diabetes","tag-g7-15-day","tag-health-canada"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/posts\/129220","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/comments?post=129220"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/posts\/129220\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/media\/129221"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/media?parent=129220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/categories?post=129220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/canada\/wp-json\/wp\/v2\/tags?post=129220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}